Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo

NCT00762411 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1111

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: LY450139
DRUG: Placebo

Sponsor

Eli Lilly and Company